E-DRUG: Relaunch of Essential Medicines Monitor
----------------------------------------
[Welcome back! - Moderator]
Dear E-Druggers,
We are very pleased to announce the relaunch of the Essential Medicines
Monitor. You may recall the Essential Drugs Monitor, a 36 page A3
publication with a green border on the pages. This was published for
more that 25 years and served as a very important guide to issues
concerning essential drugs.
After an interruption in publication, we have decided to relaunch the
publication as an electronic newsletter on the web. The URL is
http://www.who.int/medicines/publications/monitor/en/index.html This URL
provides a link to past editions and the present first edition. Our
intention is to publish two or three short articles about 10 times per
year.
In this first edition we have articles about the relaunch, the
readership survey and a major study on adherence to ARV medicines in
East Africa.
Issue 1 - October 2009
Full issue
http://www.who.int/entity/medicines/publications/monitor/EMM_Issue_1_200
9.pdf [pdf 1.12Mb]
Editorial
We are back - new name, same concept
http://www.who.int/entity/medicines/publications/monitor/EMM_art1Issue_1
_2009.pdf [pdf 331kb]
Hans V. Hogerzeil reveals more about the Essential Medicines Monitor.
Article 1
You tell us what you think: results of the Monitor's readership survey
http://www.who.int/entity/medicines/publications/monitor/EMM_art2Issue_1
_2009.pdf [pdf 282kb]
Kiki de Jong gives an overview.
Article 2
Developing standard methods to monitor adherence to antiretroviral
medicines and treatment defaulting in resource-poor settings
http://www.who.int/entity/medicines/publications/monitor/EMM_art3Issue_1
_2009.pdf [pdf 591kb]
John Chalker and colleagues provide an insight into one of the most
important public health issues of our times.
We are hoping to encourage reader responses to the articles. Once you
have read an article you will be able to send in a response and these
will be posted on the web site for other readers to read. Such comments
should be sent to emmonitor@who.int .
As before we welcome submission of short articles that address an issue
important to the Essential Medicines movement. We are particularly
interested in articles from authors in developing countries who are
describing new ways of improving access and use of essential medicines.
Guidelines for authors are available at
http://www.who.int/entity/medicines/publications/monitor/en/emmauthorgui
des.pdf
We are concerned about readers without web access and for these people
we will offer to send the individual articles as attached files. To
request such files please send a message to emmonitor@who.int
We look forward to your feedback.
Richard Laing and Kathleen Hurst
Editors Essential Medicines Monitor
Medicine Information and Evidence for Policy,
Department of Essential Medicines and Pharmaceutical Policies
World Health Organization
CH-1211 Geneva 27, Switzerland
Tel 41 22 791 4533
Fax 41 22791 4167
E-mail laingr@who.int & hurstk@who.int